雙星新材(002585.SZ)業績快報:2020年度淨利潤升315.42%至7.21億元
格隆匯 2 月 26日丨雙星新材(002585.SZ)披露2020年度業績快報,實現營業總收入50.61億元,同比增長13.17%;利潤總額8.32億元,同比增長322.16%;歸屬於上市公司股東的淨利潤7.21億元,同比增長315.42%;基本每股收益0.623元。
公司堅定推進圍繞新材料的五大板塊發展,提升效益,年內新材料的五大板塊實現效益佔全部效益60%以上。上年實施了設備工藝技術改造,本年實現產線提速增效;堅持不斷狠抓技術研發、產品開發,調優產品結構,實現創新增效;堅持“三足鼎立”營銷戰略,實現國內、國外市場新突破,增銷增效。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.